期刊文献+

胰岛素控制血糖对糖尿病大鼠阴茎勃起功能障碍的防治 被引量:1

Protective effects of insulin on erectile function in rats with streptozotocin-induced diabetes
原文传递
导出
摘要 目的:观察利用胰岛素严格控制血糖对糖尿病性勃起功能障碍(DMED)防治效果。方法年龄8周的健康Sprague-Dawley(SD)大鼠,STZ腹腔注射诱导糖尿病,监测血糖两个月诱导DMED模型,分正常对照组(NC),糖尿病安慰剂治疗组(DM),糖尿病胰岛素治疗组(DM-Inshulin)胰岛素每次2~6个单位,一天2次腹腔注射,连续治疗4周,早晚监测血糖。治疗结束后检测阴茎海绵体神经刺激下阴茎海绵体内压与平均动脉血压(ICP/MAP)评估勃起功能。留取阴茎组织进行组织学检测。结果 DM-Insulin组大鼠血糖和糖化血红蛋白得到有效控制,虽然勃起功能(以ICP/MAP检测)比较DM 组有所改善,但是比较NC组显著降低。DM-Insulin组大鼠阴茎海绵体内皮细胞标记物vWF、平滑肌等组织学病理变化及组织细胞凋亡指数比较DM组显著改善,但仍未恢复至NC组水平。结论糖尿病大鼠利用胰岛素严格控制血糖水平,可部分改善阴茎勃起功能和阴茎海绵体病理变化,但是不能完全修复勃起功能障碍的病理变化,这可能与糖尿病糖基化终末产物及其受体(AGE-RAGE)相关代谢记忆有关,有待于进一步深入研究。 Objective To investigate the therapeutic effects of insulin on eretile dysfunction in a rat model with streptozotocin-induced diabetes. Methods The diabetic erectile dysfunction (DMED) rat model was made by injecting the male 8-week-old Sprague-Dawley rats intraperitoneally with vehicle or freshly prepared 60 mg/kg streptozocin, and blood glucose level was measured in the later experiments. Then the rats were divided into three groups: the normal control group (N), the diabetes group (DM) and the diabetes plus insulin therapy group (DM+Insulin). 8 weeks after STZ injection, the DM+Insulin group were treated with 2~6 units of neutral protamine Hagedorn twice a day for 4 weeks through subcutaneous injection. After the final treatment, all rats were tested for erectile function by measuring the intracavernous pressure and mean arterial pressure (ICP/MAP), and the penile was harvested for histology study. Results Although the glycemic level was tightly controlled by insulin in the therapy group, ICP/MAP level was partially restored compared to that of the normal control group, so with the endothelial and smooth muscle contents and apoptosis index. Conclusion Insulin could partially restore the erectile functions and pathology changes in the streptozotocin-induced diabetes rat model. Further studies are needed to investigate the underlying mechanisms in the processes of diabetic erectile dysfunction.
出处 《中国男科学杂志》 CAS CSCD 北大核心 2014年第3期6-11,共6页 Chinese Journal of Andrology
基金 国家自然科学基金资助项目(编号81270693)
关键词 勃起功能障碍 糖尿病 胰岛素 erectile dysfunction diabetes mellitus insulin
  • 相关文献

参考文献15

  • 1Shabsigh R, Klein LT, Seidman S, et al. Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 1998; 52(5): 848-852.
  • 2Fedele D. Therapy Insight: sexual and bladder dysfunction associated with diabetes mellitus. Nat Clin Pract Urol 2005; 2(6): 282-290; quiz 309.
  • 3Israilov S, Shmuely J, Niv E, et al. Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus. Int JImpot Res 2005; 17(5): 431-436.
  • 4Van Den Eeden SK, Sarma AV, Rutledge BN, etal. Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes:Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC)study. Diabetes Care 2009; 32(4): 664-670.
  • 5Ratzmann KP. [Therapeutic strategy for type 2 diabetes- -clear outcome. Results of the United Kingdom Prospective Diabetes Study (UKPDS)l. FortschrMed 1999; 117(5): 45-46.
  • 6Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on developmentand progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003; 290(16): 2159-2167.
  • 7Navarrete RV, Munoz JG, Martin LL, et al. Metabolic syndrome and erectile dysfunction. Arch Esp Urol 2010; 63(8): 673-678.
  • 8Kirby RS, Lue TF. An atlas of erectile dysfunction (Second edition). International Publishers in Medicine, Science & Technology 2004.
  • 9Zhou F, Li GY, Gao ZZ, etal. The TGF- 13 1/Smad/CTGF pathway and corpus cavernosum fibrous-muscular alterations in rats with streptozotocin-induced diabetes. J Andro12012; 33(4): 651-659.
  • 10Chrisholm DJ. The Diabetes Control and Complications Trial (DCCT). A milestone in diabetes management. Med JA ust 1993; 159(11-12):721-723.

同被引文献14

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部